Clinical Trial Update: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP [Phase 2]

View source ↗

Summary

A Phase 2 trial in Chinese patients with Breakthrough Cancer Pain evaluated the effectiveness and tolerability of inhaled fentanyl aerosol at 25 µg per dose; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breakthrough Cancer Pain

Drugs mentioned

• Inhaled fentanyl aerosol (fentanyl)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Breakthrough Cancer Pain | Phase 2 | Status: COMPLETED